Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review
- PMID: 12350192
- DOI: 10.1001/jama.288.13.1610
Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review
Abstract
Context: Hysteroscopy (direct endoscopic visualization of the endometrial cavity) is used extensively in the evaluation of common gynecologic problems, such as menorrhagia and postmenopausal bleeding. However, there is a continuing debate about the value of this technology in the diagnosis of serious endometrial disease.
Objective: To determine the accuracy of hysteroscopy in diagnosing endometrial cancer and hyperplasia in women with abnormal uterine bleeding.
Data sources: Relevant articles were identified through searches of the Cochrane Library, MEDLINE, and EMBASE (1984-2001), manual searches of bibliographies of known primary and review articles, and contact with manufacturers.
Study selection: Studies were selected blindly, independently, and in duplicate if accuracy of hysteroscopy was estimated in women with abnormal uterine bleeding, using histopathologic findings as a reference standard. Our search identified 3486 articles; 208 of these were deemed to be potentially eligible and were retrieved for detailed data extraction. Sixty-five primary studies were analyzed, including 26 346 women.
Data extraction: Data were abstracted on characteristics and quality from each study. Results for diagnostic accuracy were extracted to form 2 x 2 contingency tables separately for endometrial cancer and endometrial disease (cancer, hyperplasia, or both). Pooled likelihood ratios (LRs) were used as summary accuracy measures.
Data synthesis: The pretest probability of endometrial cancer was 3.9% (95% confidence interval [CI], 3.7%-4.2%). A positive hysteroscopy result (pooled LR, 60.9; 95% CI, 51.2-72.5) increased the probability of cancer to 71.8% (95% CI, 67.0%-76.6%), whereas a negative hysteroscopy result (pooled LR, 0.15; 95% CI, 0.13-0.18) reduced the probability of cancer to 0.6% (95% CI, 0.5%-0.8%). There was statistical heterogeneity in pooling of LRs, but an explanation for this could not be found in spectrum composition and study quality. The overall accuracy for the diagnosis of endometrial disease was modest compared with that of cancer, and the results were heterogeneous. The accuracy tended to be higher among postmenopausal women and in the outpatient setting.
Conclusion: The diagnostic accuracy of hysteroscopy is high for endometrial cancer, but only moderate for endometrial disease (cancer or hyperplasia).
Similar articles
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysis.Eur J Obstet Gynecol Reprod Biol. 2016 Feb;197:147-55. doi: 10.1016/j.ejogrb.2015.12.008. Epub 2015 Dec 19. Eur J Obstet Gynecol Reprod Biol. 2016. PMID: 26748390
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.Cochrane Database Syst Rev. 2002;(3):CD001124. doi: 10.1002/14651858.CD001124. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2014 Jul 29;(7):CD001124. doi: 10.1002/14651858.CD001124.pub2. PMID: 12137619 Updated.
-
Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.Cochrane Database Syst Rev. 2004;(3):CD000402. doi: 10.1002/14651858.CD000402.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2009 Apr 15;(2):CD000402. doi: 10.1002/14651858.CD000402.pub3. PMID: 15266429 Updated.
Cited by
-
Accuracy of Transvaginal Ultrasonography, Hysteroscopy and Uterine Curettage in Evaluating Endometrial Pathologies.Rev Bras Ginecol Obstet. 2016 Oct;38(10):506-511. doi: 10.1055/s-0036-1593774. Epub 2016 Oct 21. Rev Bras Ginecol Obstet. 2016. PMID: 27769088 Free PMC article.
-
Hysteroscopy in the management of endometrial hyperplasia and cancer in reproductive aged women: new developments and current perspectives.Transl Cancer Res. 2020 Dec;9(12):7767-7777. doi: 10.21037/tcr-20-2092. Transl Cancer Res. 2020. PMID: 35117379 Free PMC article. Review.
-
Building decision trees for diagnosing intracavitary uterine pathology.Facts Views Vis Obgyn. 2009;1(3):182-8. Facts Views Vis Obgyn. 2009. PMID: 25489463 Free PMC article. Review.
-
Fertility preservation in endometrial cancer patients: options, challenges and perspectives.Ecancermedicalscience. 2020 May 6;14:1030. doi: 10.3332/ecancer.2020.1030. eCollection 2020. Ecancermedicalscience. 2020. PMID: 32419842 Free PMC article. Review.
-
Global Trends in Incidence and Mortality Rates of Endometrial Cancer Among Individuals Aged 55 years and Above From 1990 to 2021: An Analysis of the Global Burden of Disease.Int J Womens Health. 2025 Mar 6;17:651-662. doi: 10.2147/IJWH.S499435. eCollection 2025. Int J Womens Health. 2025. PMID: 40066179 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical